Shaalan Beg: Kimryn Rathmell and I highlight some of the NCI initiatives that can guide our path forward
Shaalan Beg, Senior Advisor to the Director for Clinical and Translational Trials at
“‘Leading change in cancer clinical trials, because our patients cannot wait.’
Kimryn Rathmell and I highlight some of the National Cancer Institute (NCI) initiatives that can guide our path forward.
The NCI is testing innovation in cancer clinical trials through data-driven solutions and creating partnerships.
While the last few years have seen tremendous growth, there is so much work to do.”
Quoting ‘s post:
“This just in! In ‘Leading Change in Cancer Clinical Research, Because Our Patients Can’t Wait,’ NCI Director Kimryn Rathmell and Shaalan Beg discuss the importance of the need for innovative transformations in clinical research.”
Read further.
Source: Shaalan Beg/LinkedIn and
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023